خبرة
2019 - 2022
جامعة العلوم الصحية، كلية الطب، مستشفى مدينة أنقرة، عيادة أمراض القلب، أنقرة
2017 - 2019
جامعة العلوم الصحية، كلية الطب، تركيا، مستشفى التدريب والتخصص العالي، عيادة أمراض القلب، أنقرة،
2012 - 2017
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
2012 - 2017
جامعة كارابوك، كلية الطب، قسم أمراض القلب
2006 - 2006
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
2001 - 2006
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
1996 - 2001
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
تعليم
2017 جامعة كارابوك، كلية الطب، قسم أمراض القلب
2006 مستشفى التدريب والبحوث التخصصية العليا في تركيا، عيادة أمراض القلب
2001 مستشفى التدريب والبحوث التخصصية العليا في تركيا، أنقرة، أمراض القلب
1996 جامعة أنقرة، كلية الطب
اقرأ المزيدخبرة
2019 - 2022
جامعة العلوم الصحية، كلية الطب، مستشفى مدينة أنقرة، عيادة أمراض القلب، أنقرة
2017 - 2019
جامعة العلوم الصحية، كلية الطب، تركيا، مستشفى التدريب والتخصص العالي، عيادة أمراض القلب، أنقرة،
2012 - 2017
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
2012 - 2017
جامعة كارابوك، كلية الطب، قسم أمراض القلب
2006 - 2006
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
2001 - 2006
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
1996 - 2001
مستشفى تركيا للتدريب والتخصص العالي والبحث، عيادة أمراض القلب، أنقرة،
تعليم
2017 جامعة كارابوك، كلية الطب، قسم أمراض القلب
2006 مستشفى التدريب والبحوث التخصصية العليا في تركيا، عيادة أمراض القلب
2001 مستشفى التدريب والبحوث التخصصية العليا في تركيا، أنقرة، أمراض القلب
1996 جامعة أنقرة، كلية الطب
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
اقرأ المزيد
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Dr. Murat Balanlı is an experienced internal medicine specialist with over 35 years in the field of modern medicine. Since completing his medical education, Dr. Balanlı has continuously expanded his expertise, ultimately embracing a holistic approach to healthcare. Rather than seeing holistic medicine as an alternative, he regards it as an essential extension of conventional treatment that focuses on restoring the unity of mind, body, and spirit. His philosophy, rooted in the idea that medicine is a branch of philosophy, aims to treat not only physical symptoms but also the underlying disruptions to an individual’s overall sense of well-being.
Dr. Balanlı's commitment to lifelong learning, his respect for the arts, and his passion for exploring new perspectives on health have enriched his practice and deepened his connection with patients. His experience includes positions in hospital administration, health institution management, and public health, equipping him with a comprehensive understanding of the healthcare system and patient care at various levels.
Doctor of Medicine (MD)
Ege University, Faculty of Medicine, 1988
Specialist Training in Internal Medicine
Tepecik Training and Research Hospital, 1994
Master’s Degree in Health Institutions Management
Başkent University, Faculty of Social Sciences, 2012
Founder and Head Practitioner
2014 - Present
Founded and oversees the Healthy Living Clinic, which offers personalized holistic treatment plans to patients. Here, Dr. Balanlı integrates modern medicine with holistic practices, aiming to support patients in achieving both physical health and emotional well-being.
Hospital Administrator
2015 - 2018
Managed administrative and operational functions at one of Turkey's leading children's hospitals, ensuring high standards of healthcare delivery.
Regional Director of Health Affairs
2004 - 2009
Oversaw healthcare services and managed regional health affairs for SGK, contributing to policy-making and service delivery improvements across the region.
Board Member
2009 - 2012
Served on the SGK Board of Directors, actively involved in shaping healthcare policies and advocating for quality, affordable healthcare.
Chief Physician
2003 - 2008
Directed medical services, focusing on the integration of patient-centered care with evidence-based medical practices.
Chief Physician
1996
Completed mandatory service as a physician, gaining foundational experience in diverse clinical settings.
Dr. Balanlı has shared his insights on holistic medicine through articles, presentations, and community health talks, with a focus on bridging modern and holistic approaches. His dedication to sharing knowledge has made him a respected figure in both traditional and holistic medical communities.
Dr. Murat Balanlı is an experienced internal medicine specialist with over 35 years in the field of modern medicine. Since completing his medical education, Dr. Balanlı has continuously expanded his expertise, ultimately embracing a holistic approach to healthcare. Rather than seeing holistic medicine as an alternative, he regards it as an essential extension of conventional treatment that focuses on restoring the unity of mind, body, and spirit. His philosophy, rooted in the idea that medicine is a branch of philosophy, aims to treat not only physical symptoms but also the underlying disruptions to an individual’s overall sense of well-being.
Dr. Balanlı's commitment to lifelong learning, his respect for the arts, and his passion for exploring new perspectives on health have enriched his practice and deepened his connection with patients. His experience includes positions in hospital administration, health institution management, and public health, equipping him with a comprehensive understanding of the healthcare system and patient care at various levels.
Doctor of Medicine (MD)
Ege University, Faculty of Medicine, 1988
Specialist Training in Internal Medicine
Tepecik Training and Research Hospital, 1994
Master’s Degree in Health Institutions Management
Başkent University, Faculty of Social Sciences, 2012
Founder and Head Practitioner
2014 - Present
Founded and oversees the Healthy Living Clinic, which offers personalized holistic treatment plans to patients. Here, Dr. Balanlı integrates modern medicine with holistic practices, aiming to support patients in achieving both physical health and emotional well-being.
Hospital Administrator
2015 - 2018
Managed administrative and operational functions at one of Turkey's leading children's hospitals, ensuring high standards of healthcare delivery.
Regional Director of Health Affairs
2004 - 2009
Oversaw healthcare services and managed regional health affairs for SGK, contributing to policy-making and service delivery improvements across the region.
Board Member
2009 - 2012
Served on the SGK Board of Directors, actively involved in shaping healthcare policies and advocating for quality, affordable healthcare.
Chief Physician
2003 - 2008
Directed medical services, focusing on the integration of patient-centered care with evidence-based medical practices.
Chief Physician
1996
Completed mandatory service as a physician, gaining foundational experience in diverse clinical settings.
Dr. Balanlı has shared his insights on holistic medicine through articles, presentations, and community health talks, with a focus on bridging modern and holistic approaches. His dedication to sharing knowledge has made him a respected figure in both traditional and holistic medical communities.
DR. Arzu Musaeva
Education: Azerbaijan Medical University.
Specialization: therapist
Working hours and days: weekdays 10:00-15:00.
Training and membership:
16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.
02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.
improvement.
01-30.12.2005 thematic improvement in the course “Chronic renal failure”.
22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.
26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,
Germany).
12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova
23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.
28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).
13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).
14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-
Baden, Germany).
20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,
Germany).
27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.
02/16/2010. "Homotoxicology" Dr. Alta Smith.
05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.
Joachim Bandlow.
21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.
04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.
10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"
"Sharing Methods" by Dr. Jurgen Frost.
07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"
refresher course.
11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.
10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat
(Baden-Baden, Germany).
12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).
05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard
Flechsig (Germany).
10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).
12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).
01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).
05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).
06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).
04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).
21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).
31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).
10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).
12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,
Germany).
2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.
2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier
(Switzerland).
14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.
honey. Arturo Obirne (Colombia).
15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer
(Baden-Baden, Germany).
04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.
21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"
Doctor med. Siddhartha Popat (Baden-Baden, Germany).
01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried
Preussler (Germany).
05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca
05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag
06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.
14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne
(Colombia).
Based on the results of successful treatment of trophic ulcers of various origins with biological preparations
Received the Hans-Heinrich Reckeweg Prize for clinical cases.
Examinations and treatment performed:
• Bioregulatory therapy of all therapeutic diseases.
• Atherosclerosis, stenosis, occlusion of peripheral arteries.
• Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.
• Peripheral nerve neuropathy.
• Diabetic paw, osteoarthropathy, osteomyelitis.
• Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus
treatment and prevention of delayed complications in the lower extremities.
• Gangrenous pyoderma.
• Treatment of trophic ulcers.
اقرأ المزيدDR. Arzu Musaeva
Education: Azerbaijan Medical University.
Specialization: therapist
Working hours and days: weekdays 10:00-15:00.
Training and membership:
16.02-31.03.2000 thematic development of the cycle “Current issues of infectious diseases”.
02.01-15.02.2001 thematic cycle “Clinical pharmacotherapy of internal diseases”.
improvement.
01-30.12.2005 thematic improvement in the course “Chronic renal failure”.
22.11-27.12.2005 "Applied Homotoxicology" (56 hours) prof. Safihan Gasanov.
26-30.01.2006 "Applied Homotoxicology" (36 hours) Dr. Klaus Kuestermann (Baden-Baden,
Germany).
12-24.11.2006 "Applied Homotoxicology" (48 hours) Doctor of Technical Sciences Elena Nekrasova
23-28.04.2007 "Homeoisopathy" Dr. Burkhard Flechsig.
28.05-02.06.2007 "Sanum Therapy" Dr. Anita Krake (Germany).
13.12. 2008. “Microbiological Therapy” Doctor of Medical Sciences Michael Schreiber (Germany).
14-18.03.2008 "Module B" Dr. Marion Krasnitzer-Geyer, Dr. med. Siddhartha Popat (Baden-
Baden, Germany).
20-22.06.2008. "Acupuncture and Homeosiniatry" Dr. med. Siddhartha Popat (Baden-Baden,
Germany).
27-29.11.2009. "Introduction to Homeosiniatry" Dr. med. Joachim Bandlow.
02/16/2010. "Homotoxicology" Dr. Alta Smith.
05-09.11.2010. Course "Applied Homotoxicology" (36 hours). Dr. med. Burkhard Flechsig, Dr. med.
Joachim Bandlow.
21-22. 01.2011. "Introduction to Isopathy and Sanum Therapy". Med. Thomas Rau.
04.04.2011. "Microbiological Therapy" Dr. Kerstin Rasch, Dr. Volker Rusch.
10.20.2013. "Traditional medicine with biological medicine in diseases of the endocrinological and lymphatic systems"
"Sharing Methods" by Dr. Jurgen Frost.
07.04-02.05.2014 "Azerbaijan State Medical Institute named after A.Aliyev"
refresher course.
11/12/2014. "Inflammation: A New Concept" by Dr. Alta Smith.
10-11.04.2015. "Diabetes, Stress and Associated Diseases" Dr. med. Siddhartha Popat
(Baden-Baden, Germany).
12-16.05.2015. "Neurology, autoimmune diseases" Dr. of Medical Sciences Thomas Rau (Switzerland).
05/28/2015. "Basics of acid-base balance" "Hormones and health" Dr. med. Burkhard
Flechsig (Germany).
10.21.2015. "Fundamentals of Oncology" by Dr. Gerhard Reiss (Germany).
12/21/2015. "Mesotherapy" Dr. Alta Smith (Germany).
01-03.04.2016. Dr. "Allergy, Inflammation, Stress". Bert Hannosset (Germany).
05/28-29/2016 “Aesthetic Medicine” Dr. Tatiana Rivkina (Italy).
06/13-14/2016 “Fibromyalgia, Gout, Psoriasis” Dr. med. Gerhard Reis (Germany).
04-08.10.2016. "Mucosa Syndrome" Dr. Arturo Obirne (Colombia).
21.10. 2016. "Microbiological Therapy" by Dr. Uwe Peters (Germany).
31.10-01.11.2016. "Thyroid depletion syndrome" Dr. Gerhard Reiss (Germany).
10-11.11.2017. "Microbiological therapy – the basis of regulation" Dr. Uwe Peters (Germany).
12.2017. "Neurotherapy and Homotoxicology" Dr. med. Siddhartha Popat (Baden-Baden,
Germany).
2017. "Metabolic Syndrome" Dr. med. Annette Jaensch.
2017. "Healthy Aging, Proven Remedies in Integrative Medicine", Dr. Ralf Ottmaier
(Switzerland).
14-20.05.2018. "From segment to barrier, nutrition and inflammation, vitamin C and diabetes", doctor.
honey. Arturo Obirne (Colombia).
15-17.11.2018 "Elimination Therapy Methods, Success in Old Age" Dr. Marion Krasnitzer-Geyer
(Baden-Baden, Germany).
04.2018. "Bioregulatory treatment of chronic infections" Dr.rer.nat. Petra Grüning.
21-23.09.2018. "Possibilities of treating degenerative diseases using systemic bioregulatory medicine"
Doctor med. Siddhartha Popat (Baden-Baden, Germany).
01/25/2019. "Basics of mistletoe therapy with Helixor and its application in practice" Doctor of Medical Sciences Christfried
Preussler (Germany).
05/11/2019 “Mesotherapy” Dr. Nicoletta Frasca
05/14/2019. "Sanum Therapy for Liver Diseases" by Dr. Dieter Sonntag
06.04.2019. "Isn't fatigue the call of the liver?" Dr. Petra Grüning.
14-19.10.2019. "Bioregulatory treatment of dermatological diseases". med. Arturo Obirne
(Colombia).
Based on the results of successful treatment of trophic ulcers of various origins with biological preparations
Received the Hans-Heinrich Reckeweg Prize for clinical cases.
Examinations and treatment performed:
• Bioregulatory therapy of all therapeutic diseases.
• Atherosclerosis, stenosis, occlusion of peripheral arteries.
• Varicose veins, thrombophlebitis, thrombosis, lymphostasis of peripheral veins.
• Peripheral nerve neuropathy.
• Diabetic paw, osteoarthropathy, osteomyelitis.
• Detoxification and bioregulation of blood glucose at the cellular level. Diabetes mellitus
treatment and prevention of delayed complications in the lower extremities.
• Gangrenous pyoderma.
• Treatment of trophic ulcers.